Regression of Xanthelasmas With Statin Treatment in a Normolipidemic Patient
Bibliographic record
Abstract
Letters19 May 2020Regression of Xanthelasmas With Statin Treatment in a Normolipidemic PatientJulieta Lazarte, MSc and Robert A. Hegele, MDJulieta Lazarte, MScSchulich School of Medicine & Dentistry, Western University, London, Ontario, Canada (J.L., R.A.H.) and Robert A. Hegele, MDSchulich School of Medicine & Dentistry, Western University, London, Ontario, Canada (J.L., R.A.H.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L19-0797 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Xanthelasmas are asymptomatic, benign, yellowish papules or plaques that appear on or around the eyelids; they comprise cholesterol-loaded macrophages and typically develop in adulthood (1). In about half of cases, they are associated with familial hypercholesterolemia; thus, they should trigger lipid profiling (2). In patients with familial hypercholesterolemia, regression of xanthelasmas can occur with lipid-lowering drugs, such as statins (3); alirocumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (4); or probucol (1), an antioxidant that is used to lower cholesterol levels but is no longer available in North America. Also, in 1 report regression of xanthelasmas occurred ...References1. Laftah Z, Al-Niaimi F. Xanthelasma: an update on treatment modalities. J Cutan Aesthet Surg. 2018;11:1-6. [PMID: 29731585] doi:10.4103/JCAS.JCAS_56_17 CrossrefMedlineGoogle Scholar2. Defesche JC, Gidding SS, Harada-Shiba M, et al. Familial hypercholesterolaemia. Nat Rev Dis Primers. 2017;3:17093. [PMID: 29219151] doi:10.1038/nrdp.2017.93 CrossrefMedlineGoogle Scholar3. Shields CL, Mashayekhi A, Shields JA, et al. Disappearance of eyelid xanthelasma following oral simvastatin (Zocor) [Letter]. Br J Ophthalmol. 2005;89:639-40. [PMID: 15834100] CrossrefMedlineGoogle Scholar4. Civeira F, Perez-Calahorra S, Mateo-Gallego R. Rapid resolution of xanthelasmas after treatment with alirocumab. J Clin Lipidol. 2016;10:1259-61. [PMID: 27678444] doi:10.1016/j.jacl.2016.07.007 CrossrefMedlineGoogle Scholar5. Schmidt HH, Manns MP. Images in hepatology. Regression of xanthelasmas in a patient with primary biliary cirrhosis after liver transplantation. J Hepatol. 1998;28:1077. [PMID: 9672187] MedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada (J.L., R.A.H.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L19-0797.This article was published at Annals.org on 18 February 2020. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDiffuse Planar Xanthoma Involving the Face in a Mask-Like Distribution 19 May 2020Volume 172, Issue 10Page: 701-702KeywordsApolipoproteinsCholesterolDisclosureDrugsDyslipidemiaFamilial hypercholesterolemiaHigh density lipoprotein cholesterolLipidsLow density lipoproteinStatins ePublished: 18 February 2020 Issue Published: 19 May 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.002 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.000 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.000 | 0.001 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".